Flawed ivermectin preprint highlights challenges of COVID drug studies.

Reardon, Sara

Reardon, Sara.

Nature ; 596(7871): 173-174, 2021 08.

Article in English | MEDLINE | ID: covidwho-1338525

Subject(s)

COVID-19 Drug Treatment; COVID-19/mortality; Clinical Trials as Topic; Ivermectin/therapeutic use; Preprints as Topic; Retraction of Publication as Topic; Antiparasitic Agents/therapeutic use; Clinical Trials as Topic/ethics; Clinical Trials as Topic/standards; Humans; Pandemics; Plagiarism; Preprints as Topic/ethics; Preprints as Topic/standards; Research Personnel/ethics; Research Personnel/standards; Sample Size; Scientific Misconduct/legislation & jurisprudence; World Health Organization

Keywords

Public health; Publishing; Research data; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Retraction of Publication as Topic / Ivermectin / Clinical Trials as Topic / Preprints as Topic / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Nature Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google